1. DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes
- Author
-
Léa Meunier, Eric Letouzé, Gabrielle Couchy, Quentin Bayard, Stefano Caruso, Théo Z. Hirsch, Amélie Roehrig, Josep M. Llovet, Julien Calderaro, Jean-Frédéric Blanc, Jean-Charles Nault, Sandrine Imbeaud, Jessica Zucman-Rossi, HAL-SU, Gestionnaire, Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Hôpital Jean Verdier [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Unité de Formation et de Recherche Santé, Médecine, Biologie Humaine [Bobigny], Université Paris 13 (UP13)-Sorbonne Paris Cité, Icahn School of Medicine at Mount Sinai [New York] (MSSM), University of Barcelona, Institució Catalana de Recerca i Estudis Avançats (ICREA), Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], CHU de Bordeaux Pellegrin [Bordeaux], Hôpital Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), and Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université de Paris (UP)
- Subjects
Male ,Carcinoma, Hepatocellular ,epigenetic reprogramming ,Datasets as Topic ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Computational biology ,integrated genomic analysis ,Biology ,Epigenesis, Genetic ,03 medical and health sciences ,Epigenome ,Genetic Heterogeneity ,0302 clinical medicine ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,Humans ,Gene Regulatory Networks ,Epigenetics ,RNA-Seq ,Enhancer ,Gene ,030304 developmental biology ,Aged ,0303 health sciences ,DNA methylation ,Hepatology ,Liver Neoplasms ,[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology ,Methylation ,hepatocellular carcinoma ,HCCS ,Middle Aged ,[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology ,Chromatin ,independent component analysis ,030220 oncology & carcinogenesis ,Mutation ,[SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,CpG Islands ,Female ,Reprogramming - Abstract
International audience; DNA methylation patterns are highly rearranged in hepatocellular carcinomas (HCCs). However, diverse sources of variation are intermingled in cancer methylomes, precluding the precise characterization of underlying molecular mechanisms. We developed a computational framework (methylation signature analysis with independent component analysis [MethICA]), leveraging independent component analysis (ICA) to disentangle the diverse processes contributing to DNA methylation changes in tumors. Applied to a collection of 738 HCCs, MethICA unraveled 13 stable methylation components (MCs) preferentially active in specific chromatin states, sequence contexts, and replication timings. These included signatures of general processes associated with gender and age but also new signatures related to specific driver events and molecular subgroups. Catenin beta 1 (CTNNB1) mutations were major modulators of methylation patterns in HCC, characterized by a targeted hypomethylation of transcription factor 7 (TCF7)‐bound enhancers in the vicinity of Wnt target genes as well as a widespread hypomethylation of late‐replicated partially methylated domains (PMDs). By contrast, demethylation of early‐replicated highly methylated domains (HMDs) was a signature of replication stress, leading to an extensive hypomethylator phenotype in cyclin (CCN)‐activated HCC. Inactivating mutations of the chromatin remodeler AT‐rich interactive domain‐containing protein 1A (ARID1A) were associated with epigenetic silencing of differentiation‐promoting transcriptional networks, also detectable in cirrhotic liver. Finally, a hypermethylation signature targeting Polycomb‐repressed chromatin domains was identified in the G1 molecular subgroup with progenitor features. Conclusion: This study elucidates the diversity of processes remodeling HCC methylomes and reveals the epigenetic and transcriptional impact of driver alterations.
- Published
- 2021
- Full Text
- View/download PDF